Quantum Light Source Matches Conventional Laser Performance in Ionization Test
A quantum light source produced ionization effects equivalent to a conventional laser 20 times more intense. The experiment marks the first reported use of quantum light to complete the initial step toward generating attosecond pulses.
nature.comResearchers demonstrated that a quantum light source can generate ionization comparable to a classical laser with 20 times higher intensity. The result was reported in a study published in Nature. Attosecond light pulses last for quintillionths of a second and are typically created using high-intensity lasers. The new source achieved the first step in the process of producing such pulses.
Jiang et al. showed that the quantum light source behaves like a classical laser of greater intensity. The team used the source to initiate atomic ionization, a necessary precursor for attosecond pulse generation. The work builds on prior research into squeezed vacuum states and nonlinear atomic interactions.
It provides a new approach for probing matter on extremely short timescales. 1038/s41586-026-10485-9.
Key Facts
Potential Impact
- 01
Researchers may explore quantum sources for attosecond pulse generation experiments.
Transparency Panel
Related Stories
NprWHO Director Visits Congo as Ebola Outbreak Spreads
The head of the World Health Organization arrived in Kinshasa to support efforts against a rare Ebola strain. Health workers face equipment shortages, community distrust, and armed conflict in affected provinces.
medpagetoday.comFDA Panel Recommends XFG Variant for Fall Covid Shots
Replimune will submit an application to the FDA for the third time. Pfizer and Innovent Biologics reached a collaboration agreement valued at up to $10.5 billion.
Benzinga Publishes Article on Biotech Stocks During Pandemic Recovery
Benzinga published an article titled 'Best Biotech Stocks Right Now' that addresses the sector's position during global recovery from the pandemic. The piece notes government institutions and professional traders are focusing on biotech companies for vaccine and booster developme…